Top Tech Companies in Boston, MA (4,106)

Resilient & Sustainable Growth: Revenue increased in FY2024 and again in FY2025 to a record ~US$56.9B, with all three lines of service expanding. Growth in the Americas and EMEA helped offset softness in parts of Asia Pacific, indicating steady, if modest, momentum.

Innovation-Driven Growth: A multi‑year push includes roughly US$1.5B to expand and scale AI capabilities, alongside AI‑enabled platforms and dedicated AI hubs/factories. These investments are positioned to extend growth beyond core assurance and tax and to support new, tech‑enabled offerings.

Strong Market Position & Advantage: As one of the Big Four with record scale and repeated “Leader” placements in independent analyst evaluations, the firm operates from a top‑tier competitive position. Rising brand value and leadership recognition in selected consulting categories reinforce commercial strength.

Strong Revenue Growth: Revenue is reported to have risen from £169.4m in 2023 to £197.0m in 2024, based on filed UK statutory accounts. Parent-company commentary for 2025 further points to higher “Other revenues” tied to this unit, reinforcing the upward trend.

Profitability: Operating profit increased to £45.9m in 2024 alongside higher profit after tax, indicating improved operating leverage. These gains are documented in UK filings as summarized by industry coverage.

Market Expansion: Customer milestones include surpassing one million globally in 2024 and one million in the UK in 2026, while a new Boston headquarters signals continued U.S. investment. Recent product and initiative rollouts (e.g., AI tools and community programs) indicate ongoing expansion efforts.

Strong Revenue Growth: Revenue is accelerating, with early‑2026 results exceeding the prior year’s pace and the full‑year outlook raised to reflect continued momentum. Large‑customer additions further reinforce top‑line expansion at scale.

Healthy Cash Flow: Operating and free cash flow remain substantial, including strong generation in Q2 2026 and across FY2025. This liquidity provides flexibility to invest while sustaining growth.

Innovation-Driven Growth: New AI‑powered capabilities—such as Bits AI offerings, GPU Monitoring, and an agent builder—were launched around Q1–Q2 2026 and at DASH 2026, supporting usage and upsell. Broader multi‑product adoption and growth in high‑ARR cohorts are highlighted across recent updates.

Strong Revenue Growth: Net revenue rose 14% year over year in Q2 2026 (12% currency‑neutral) to $9.3B, with first‑half 2026 up 15% and full‑year 2025 up 16% (15% currency‑neutral). These results indicate sustained top‑line momentum across recent periods.

Diversified Revenue Streams: Value‑Added Services & Solutions grew 20% in Q2 2026 (18% currency‑neutral) and 23% in 2025, outpacing Payment Network growth. This mix shift adds a faster‑growing second engine alongside the core network.

Resilient & Sustainable Growth: Transaction fundamentals remained healthy in Q2 2026—gross dollar volume +8% to $2.9T, cross‑border +12%, and switched transactions +9% (local‑currency). Multi‑year growth from 2025 into the first half of 2026 underscores durable momentum.

Strong Revenue Growth: Q2 2026 total net revenue rose 4% sequentially to $15.9 billion. Integration of Discover and Brex contributed to higher non‑interest income and broader payments capabilities.

Profitability: Q2 2026 net income reached $3.0 billion, up from $2.2 billion in Q1 2026, alongside a net interest margin of 8.01%. Management also cited strong credit performance, including a $662 million reserve release.

Market Expansion: Acquisition‑driven scale is broadening reach, with the Discover deal (closed May 18, 2025) and Brex (closed April 7, 2026) adding network and corporate card/spend‑management capabilities. Balance‑sheet growth continued in Q2 2026 as period‑end loans rose 2% to $457.2 billion and total assets reached $673.8 billion.

Innovation-Driven Growth: New AI-focused capabilities (e.g., AI Connectors built on Model Context Protocol) and a stated push to be an “AI platform for biotech R&D” signal ongoing product investment. Reported usage of Benchling AI across 500 biotech companies underscores adoption of these innovations.

Strategic Partnerships: The January 2026 collaboration with Lilly’s TuneLab is positioned to bring proprietary models to scientists across Benchling’s customer base. Acqui-hires of ReSync Bio and Sphinx Bio in 2025 were used to accelerate the AI roadmap.

Strong Revenue Growth: ARR was independently estimated around the low-$200 millions by mid-2024 with year-over-year increases, indicating continued top-line expansion. While the pace has moderated versus earlier years, the trajectory remains positive.

Strong Revenue Growth: Revenue momentum is portrayed as rapid, with inclusion on the 2026 Inc. 5000 and statements that ARR has risen markedly since 2022. Milestones across 2024–2026 indicate sustained scaling rather than a one‑off spike.

Investor Backing & Capital Strength: Financing rounds of $45M (2024) and $80M (2026) brought total capital to about $160M and a valuation near $955M, signaling ample resources to execute. The company links this capital to expansion of AI capabilities and data products.

Strong Market Position & Advantage: Customer footprint reportedly surpassed 500 by mid‑2026, including penetration into 16 of the top 20 MedTech companies with named logos like BD, Olympus, and Teleflex. This depth of enterprise adoption suggests meaningful competitive positioning within MedTech.

Strong Revenue Growth: External growth lists (Deloitte Technology Fast 500 and Inc. 5000) and disclosed multi‑year gains indicate accelerating top‑line momentum. Consecutive placements and upward movement on these rankings reinforce the trajectory.

Market Expansion: A UK office launch to support UK/EMEA and the introduction of International Payments signal geographic expansion and a broader commercial footprint. The 2025 rebrand was framed as enabling a larger, global push for a NetSuite‑native platform.

Innovation-Driven Growth: Regular release trains (e.g., 2025.1/2025.2) and new capabilities such as Invoice AI, Touchless Invoice Processing, and planned e‑invoicing reflect sustained product investment. Compatibility updates tied to NetSuite versions point to a maturing, actively developed platform.

Strong Market Position & Advantage: Recognition as a Leader in the 2026 Gartner Magic Quadrant for Workplace Experience Applications signals strong execution and helps with shortlist placement in enterprise cycles. It reflects visibility and credibility within its category.

Innovation-Driven Growth: Continued product releases—especially AI-driven scheduling and refreshed analytics—indicate active R&D and a roadmap aligned to hybrid-work needs. This cadence typically tracks with active usage and retention motions.

Market Expansion: Launching the One Workplace Platform on Google Cloud Marketplace opens a new procurement channel that can accelerate expansion with enterprise buyers. This move complements a broad customer footprint highlighted across regions and industries.

Strong Market Position & Advantage: Repeated Leader placements in Gartner’s DEX Magic Quadrant (2024–2026) and Forrester’s 2024 EUEM Wave indicate durable competitive standing and sustained category momentum. These recognitions coincide with communications citing 1,200–1,500+ customers and 20M+ endpoints, underscoring broad enterprise adoption.

Product Line Growth: New offerings such as Adopt on Infinity (2025) and the Spark personal IT agent (2026), plus integrations like GoTo/Rescue and a government-focused AWS Marketplace listing, expand use cases and routes to market. The 2024 acquisition of AppLearn further broadened capabilities into digital adoption.

Investor Backing & Capital Strength: A late‑2025 majority investment by Vista Equity Partners at an approximately $3B valuation signals strong external confidence and provides resources for scaling. This step-up from the 2021 round supports continued product and go‑to‑market execution.

Profitability: Q2 2026 delivered positive GAAP operating income of $3.0M and non‑GAAP operating income of $28.9M, with management raising the 2026 non‑GAAP operating income outlook. This indicates margin improvement even as the top line softens.

Healthy Cash Flow: Free cash flow was $31.9M in Q2 2026 and management is targeting around $125–$135M for full‑year 2026. This ongoing cash generation underscores improved efficiency during a reset year.

Investor Backing & Capital Strength: Cash and short‑term investments increased to about $703M as of June 30, 2026, up from roughly $657M at year‑end 2025. This liquidity provides flexibility amid slower ARR and revenue trends.

Resilient & Sustainable Growth: Square gross profit and payment volumes are rising with signs of acceleration in 2026; Q2 2026 gross profit reached about $1.16B and GPV increased at a low‑teens rate year over year. Management also raised the full‑year outlook at the Block level, indicating momentum in which Square is contributing.

Market Expansion: Traction with larger, multi‑location sellers and strong international GPV growth indicate expansion beyond very small businesses. U.S. GPV also accelerated to its strongest pace since Q2 2023, complementing faster non‑U.S. growth.

Innovation-Driven Growth: Hardware and AI are highlighted as fast‑compounding capabilities, and Square Financial Services has begun processing acquiring volume. An expanded ISO and partner ecosystem is bringing in more new sellers and deepening product adoption.

Product Line Growth: Active ETFs have been added steadily since December 2024, bringing the lineup to 11 by June 2026 with ETF assets above $2.7B by May 31, 2026. Parent disclosures also cite roughly US$1.2B in net inflows since launch and ending 2025 above US$1.4B in ETF AUM.

Resilient & Sustainable Growth: Assets under management show a modest upward trend from late 2024 (~$645B) to mid‑2026 (~$655B at May 31, 2026) despite normal month‑to‑month volatility. The path includes interim dips and rebounds tied to market moves and flow variability.

Profitability: Parent reports indicate higher fee income on higher average net assets and an improved pre‑tax operating margin of 35.7% in Q2 2026 versus 35.1% a year earlier. Underlying net income also ticked up year over year, signaling earnings resilience.

Investor Backing & Capital Strength: Formation Bio closed a $372M Series D on June 26, 2024 led by a16z with significant participation from Sanofi, bringing total funding to over $600M and at a material step-up in valuation. The capital is directed toward expanding its drug pipeline and AI platform.

Strategic Partnerships: A first‑in‑class AI collaboration with Sanofi and OpenAI (announced May 2024) has already produced Muse, an AI tool for patient recruitment. Additional partnering activity includes Sanofi’s 2025 deal for gusacitinib via a Formation subsidiary, signaling expanding commercial and technology ties.

Product Line Growth: Multiple in‑licensing moves in 2025–2026 (e.g., a CNS‑penetrant TYK2 inhibitor, a miR‑124 activator, and an anti‑CD226 program) broaden the portfolio. The first participant was dosed in a Phase 1 trial (BLKR201) on June 9, 2026, marking concrete clinical progression.

Strategic Partnerships: New relationships with firms such as Fidelity, Capital Group, Vanguard, and client wins like Elevation Point broaden distribution and embed the platform within major advisor ecosystems. These selections signal expanding access to workflows across large wealth programs.

Innovation-Driven Growth: Launches such as Vestmark Pulse and the opening of a Center for AI Research and Development indicate continued investment in AI-enabled capabilities. Growth in VAST and expanded tax-aware UMA features reinforce a steady cadence of new solutions.

Strong Market Position & Advantage: Scale of more than $2 trillion in assets on platform, millions of accounts, and support for 72,000+ advisors points to broad institutional adoption. Serving six of the ten largest managed-account platforms and VAS crossing $50B in AUM add evidence of an entrenched position at the high end of the market.

Strong Market Position & Advantage: Analyst recognition as a Leader in The Forrester Wave: Cybersecurity Skills and Training Platforms (Q1 2026, and previously 2023) highlights strength in current offering and strategy. Claims of 400+ customers, Fortune‑scale adoption, and visible enterprise/public‑sector footprints reinforce this positioning.

Innovation-Driven Growth: New GenAI‑powered capabilities and continued investment in the unified “Immersive One” platform indicate active product development. Frequent 2025–2026 feature launches and AI‑centric updates suggest a robust roadmap.

Strategic Partnerships: Collaborations such as Arctic Wolf joining the Cyber Million initiative and public‑sector programs (e.g., UK Defence, CyberTrust Massachusetts) signal expanding ecosystem reach. These relationships align with companies leaning into broader market expansion.

Strong Revenue Growth: Deloitte’s 2025 Technology Fast 500 ranked the company No. 244 with 325% growth, following a 2023 placement at No. 67 with 2,263% growth. These recognitions indicate sustained multi‑year top-line expansion.

Strategic Partnerships: Carrier and ecosystem ties continue to expand, including Heritage Insurance enabling text-to-start claims in 2025 and company-highlighted expanded partnerships and integrations. Such relationships point to continued carrier adoption and embedded workflows.

Product Line Growth: The August 4, 2026 launch of Unite and the June 10, 2026 agentic‑AI strategy—alongside expansion into policyholder service—show active investment and new capabilities. These moves broaden the platform beyond claims into multi‑party coordination and service operations.

Market Expansion: Headcount and footprint are described as rising to more than 15,000 employees across 40-plus offices, alongside concrete new sites in Hyderabad and a completed Chicago buildout—signals of geographic and capacity expansion. These moves indicate confidence in demand across key delivery hubs.

Innovation-Driven Growth: A dedicated Platforms & Products unit, the ZAIDYN portfolio, and AI-agent initiatives point to sustained investment in productized, AI-enabled offerings. Capability-deepening acquisitions (Digital Additive in 2024 and Torrent Consulting in 2025) further strengthen CRM and multi‑cloud life‑sciences solutions.

Strategic Partnerships: An expanded Salesforce collaboration around Agentforce and recognition as Databricks 2025 Life Sciences Partner of the Year suggest momentum in data/AI ecosystems. These alliances position the firm to capture spend where CRM, data, and AI converge in healthcare and life sciences.

Strong Revenue Growth: Company-reported updates describe a record 2024 with double-digit revenue growth and another record year in 2025 alongside rising new-business momentum. These signals point to sustained top-line expansion since going private.

Innovation-Driven Growth: Ongoing 2026 product releases, including TOS 5.3 and agentic AI capabilities across hybrid, multi‑vendor environments, indicate continued investment in the platform. Such cadence aligns with expanding use cases and market opportunity.

Strategic Partnerships: A 2026 collaboration with Akamai around microsegmentation and Zero Trust reflects deeper ecosystem reach and a broader solution footprint. This activity supports go‑to‑market expansion.

Market Expansion: Public materials indicate customer counts rising from 500+ in 2021 to more than 1,000 by mid‑2025, suggesting steady adoption. Partner motions such as becoming a Shopify Premium Partner in 2025 further extend reach and implementation capacity.

Product Line Growth: Acquisitions of Unifai (2023) and PricingHUB (2026) expand the Product Cloud from core PIM/PXM into AI‑driven enrichment and pricing, broadening wallet share opportunities. A continued 2025–2026 release cadence (e.g., AI agents, CDN, data architect enhancements) reinforces an expanding offering.

Investor Backing & Capital Strength: A $135M Series D in March 2022 underpins subsequent platform launches and acquisitions, signaling capacity to execute on product and international initiatives. This capital base supports measured expansion.